Author: Amy Adams

First therapy supported by CIRM approved by the FDA 

/ Amy Adams / Leave a comment

Image Credit: Canva stock images After 21 years (and a few months), the California Institute of Regenerative Medicine (CIRM) has hit a major milestone with its FDA approved therapy. The promise of stem cells In 2004, when California voters created CIRM to fund research with stem cells, which can divide to form many different tissues in the body. Stem cells held great potential, but scientists … Continue reading First therapy supported by CIRM approved by the FDA 

New program to help patients with rare disease

/ Amy Adams / 2 Comments

Recently, the California Institute for Regenerative Medicine (CIRM) announced a new approach for how its funding can advance treatments for people living with rare diseases. Individually, few people have any single rare disease, but in aggregate, about 30 million people in the U.S. have one of the roughly 10,000 rare diseases, and 95% have no … Continue reading New program to help patients with rare disease

20 Years of CIRM: Building the Workforce

/ Amy Adams / 1 Comment

In celebration of the California Institute for Regenerative Medicine (CIRM)’s 20th anniversary, we have been reflecting on some of the early projects, particularly the education and training programs, that we supported and their outcomes. In the beginning Today, we’re looking at our first set of grants, which we awarded in 2006 to support training programs … Continue reading 20 Years of CIRM: Building the Workforce